Cost-effectiveness Analysis of Tislelizumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Metastatic or Recurrent Nasopharyngeal Carcinoma in China
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK（2024）
Key words
cost-effectiveness,nasopharyngeal carcinoma,recurrent or metastatic,tislelizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined